Citation Impact
Citing Papers
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
2020 StandoutScience
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Predictors of Postoperative Pain and Analgesic Consumption
2009 Standout
The Significance of c-erb B-2 and p53 Immunoreactivity in Patients with Adenocarcinoma of the Esophagus
1995
Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma
1992
Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma
1993
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Extrapleural Pneumonectomy in the Multimodality Therapy of Malignant Pleural Mesothelioma
1996
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
1999 Standout
Clinically Important Drug Interactions with Anticoagulants
1996
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
National Cancer Data Base report on esophageal carcinoma
1996
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
1997
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
2004 StandoutNobel
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*
2003 Standout
Clusterin: Physiologic and pathophysiologic considerations
1995 Standout
Chemoradiotherapy of Locally Advanced Esophageal Cancer
1999 Standout
Predicting plasma protein binding of drugs: a new approach
2002
Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients
1991
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
2005 Standout
Combined-modality therapy in the treatment of local-regional esophageal cancer
1992
A Model for Planning Optimal Follow-up for Outpatients on Warfarin Anticoagulation
1992
Oral Anticoagulant Therapy
2012 Standout
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Case-control study of sudden infant death syndrome in Scotland, 1992-5
1997
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure
2002
Albumin–drug interaction and its clinical implication
2013 Standout
Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins
1999 Standout
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Esophageal Cancer
2003 Standout
The Physiologic Basis of Diuretic Synergism: Its Role in Treating Diuretic Resistance
1991
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus
1992 Standout
Urinary and plasma magnesium and risk of ischemic heart disease
2013
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 Standout
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations
1994 Standout
Lone Atrial Fibrillation in Elderly Persons
1999
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
Oesophageal carcinoma
2013 Standout
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
2002 Standout
Aging and the Anticoagulant Response to Warfarin Therapy
1992
Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction
1994
International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?
2001
Guidelines for the management of oesophageal and gastric cancer
2011
Age-associated risks of prophylactic anticoagulation in the setting of hip fracture
1994
In vivo secretion and association of clusterin (SGP‐2) in luminal fluid with spermatozoa in the rat testis and epididymis
1991
Characterization of site I on human serum albumin: concept about the structure of a drug binding site
1996
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Furosemide (Frusemide)
1990
High-Resolution and High-Throughput Protocols for Measuring Drug/Human Serum Albumin Interactions Using BIACORE
2001
Anticoagulation clinics and the monitoring of anticoagulant therapy
1988
Human seminal clusterin (SP-40,40). Isolation and characterization.
1990
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Anticoagulant drugs in the elderly: the risks usually outweight the benefits.
1988
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
1993
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Home Prothrombin Time Monitoring after the Initiation of Warfarin Therapy
1989
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Improved Survival with Neoadjuvant Therapy and Resection for Adenocarcinoma of the Esophagus
1993
Low molecular weight heparin (bemiparin sodium) and the coagulation profile of patients with heart failure
2002
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Sentinel Lymph Node Mapping of the Pleural Space
2005 StandoutNobel
Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
2010
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review.
2003 Standout
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
1991 Standout
SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment
2011 Standout
Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review.
1998 Standout
Oxaliplatin in Combination With Protracted-Infusion Fluorouracil and Radiation: Report of a Clinical Trial for Patients With Esophageal Cancer
2002
Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells.
1986 StandoutNobel
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
Age-Related Risks of Long-term Oral Anticoagulant Therapy
1988
Experience with cisplatin in treatment regimens for esophageal cancer.
1991
Magnesium in Prevention and Therapy
2015 Standout
Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma
2001
Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care
2006 Standout
Clinical Pharmacokinetics of Oral Anticoagulants
1979
RENAL, HAEMODYNAMIC, AND HORMONAL EFFECTS OF HUMAN ALPHA ATRIAL NATRIURETIC PEPTIDE IN HEALTHY VOLUNTEERS
1985
Initiation of warfarin therapy
1987
Thromboembolism and Antithrombotic Therapy in Congestive Heart Failure
1995
A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.
1979
Prediction of hemorrhage during long-term oral coumarin anticoagulation by excessive prothrombin ratio
1982
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Pharmacokinetic and Pharmacodynamic Changes in the Elderly
1998
THROMBOPHLEBITIS AND PULMONARY EMBOLISM IN THE ELDERLY PATIENT
1993
Effects of atriopeptins on relaxation and cyclic GMP levels in human coronary artery in vitro
1986 StandoutNobel
Clinical Pharmacokinetics and Pharmacodynamics of Warfarin
1986
Microalbuminuria as a predictor of clinical diabetic nephropathy
1987
Drug Disposition in Old Age
1982
Works of S. Husted being referenced
Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus.
1990
Magnesium inhibits human platelets
1996
The Binding of Phenprocoumon to Human Plasma Proteins
1979
The pharmacokinetics of frusemide are influenced by age.
1983
Protein Binding of Phenprocoumon in the Absence and Presence of Furosemide
1976
The Influence of Intravenous Furosemide on the Renal Excretion Pattern of Protein and Protein Degradation Products
1984
Individual variation in the response to phenprocoumon
1977
Increased sensitivity to phenprocoumon during methyltestosterone therapy
1976
The Determination of Naproxen by Spectrofluorometry and its Binding to Serum Proteins
1979
The influence of age on renal and extrarenal effects of frusemide.
1984
Microtechnique for simultaneous determination of immobilizing and cytotoxic sperm antibodies. Methodological and clinical studies.
1975
A Circulating Factor V Inhibitor: Possible Side Effect of Treatment with Streptomycin
1975
The influence of age on the response to anticoagulants.
1977
The effect of testis biopsy on autosensitization against spermatozoal antigens.
1974
Problems Encountered in Long‐term Treatment with Anticoagulants
1976